Literature DB >> 26445778

Use of Mouse Models in Atherosclerosis Research.

Godfrey S Getz1, Catherine A Reardon2.   

Abstract

Cardiovascular disease is the major cause of death in most developed nations and the social and economic burden of this disease is quite high. Atherosclerosis is a major underlying basis for most cardiovascular diseases including myocardial infarction and stroke. Genetically modified mouse models, particularly mice deficient in apoprotein E or the LDL receptor, have been widely used in preclinical atherosclerosis studies to gain insight into the mechanisms underlying this pathology. This chapter reviews several mouse models of atherosclerosis progression and regression as well as the role of immune cells in disease progression and the genetics of murine atherogenesis.

Entities:  

Keywords:  Atherosclerosis; Genetics; Immune system; LDL receptor deficient; Regression; apoE deficient

Mesh:

Substances:

Year:  2015        PMID: 26445778     DOI: 10.1007/978-1-4939-2929-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Animal models of cardiovascular disease as test beds of bioengineered vascular grafts.

Authors:  Sindhu Row; Daniel D Swartz; Stelios T Andreadis
Journal:  Drug Discov Today Dis Models       Date:  2018-06-18

Review 2.  Blowing up Neural Repair for Stroke Recovery: Preclinical and Clinical Trial Considerations.

Authors:  Nick S Ward; S Thomas Carmichael
Journal:  Stroke       Date:  2020-09-21       Impact factor: 7.914

3.  Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner.

Authors:  James Monslow; Leslie Todd; John E Chojnowski; Priya K Govindaraju; Richard K Assoian; Ellen Puré
Journal:  Am J Pathol       Date:  2020-02-19       Impact factor: 4.307

4.  Low ambient oxygen prevents atherosclerosis.

Authors:  Ju-Gyeong Kang; Ho Joong Sung; Marcelo J Amar; Milton Pryor; Alan T Remaley; Michele D Allen; Audrey C Noguchi; Danielle A Springer; Jaeyul Kwon; Jichun Chen; Ji-hoon Park; Ping-yuan Wang; Paul M Hwang
Journal:  J Mol Med (Berl)       Date:  2016-02-02       Impact factor: 4.599

5.  Chronic apical periodontitis exacerbates atherosclerosis in apolipoprotein E-deficient mice and leads to changes in the diversity of gut microbiota.

Authors:  Guowu Gan; Beibei Lu; Ren Zhang; Yufang Luo; Shuai Chen; Huaxiang Lei; Yijun Li; Zhiyu Cai; Xiaojing Huang
Journal:  Int Endod J       Date:  2021-11-16       Impact factor: 5.165

6.  Combined orcein and martius scarlet blue (OMSB) staining for qualitative and quantitative analyses of atherosclerotic plaques in brachiocephalic arteries in apoE/LDLR-/- mice.

Authors:  Mariusz Gajda; Agnieszka Jasztal; Tomasz Banasik; Ewa Jasek-Gajda; Stefan Chlopicki
Journal:  Histochem Cell Biol       Date:  2017-02-06       Impact factor: 4.304

Review 7.  The role of monocytosis and neutrophilia in atherosclerosis.

Authors:  Dimitry A Chistiakov; Andrey V Grechko; Veronika A Myasoedova; Alexandra A Melnichenko; Alexander N Orekhov
Journal:  J Cell Mol Med       Date:  2018-01-24       Impact factor: 5.310

8.  MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis.

Authors:  Heming Chen; Xiaoyi Li; Shuiyi Liu; Lu Gu; Xinmin Zhou
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

9.  Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome.

Authors:  Magda R Hamczyk; Vicente Andrés
Journal:  Nucleus       Date:  2019-12       Impact factor: 4.197

10.  Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon.

Authors:  Jan Bucerius; Ingrid Dijkgraaf; Felix M Mottaghy; Leon J Schurgers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.